The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population

Aims To assess the prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in the chronically paced population. Methods and Results Three hundred and seven patients were identified from attendance at routine pacemaker follow-up clinic. Subjects underwent a medical history...

Full description

Saved in:
Bibliographic Details
Published in:European heart journal Vol. 24; no. 12; pp. 1143 - 1152
Main Authors: Thackray, Simon D.R., Witte, Klaus K.A., Nikitin, Nikolay P., Clark, Andrew L., Kaye, Gerald C., Cleland, John G.F.
Format: Journal Article
Language:English
Published: Oxford Oxford University Press 01-06-2003
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims To assess the prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in the chronically paced population. Methods and Results Three hundred and seven patients were identified from attendance at routine pacemaker follow-up clinic. Subjects underwent a medical history and examination, 6-minute walk test and echocardiography. 94 (31%) had a left ventricular ejection fraction (LVEF) <40%, of whom 83 had symptoms of heart failure (70% NYHA II, 26% NYHA III and 4% NYHA IV). Heart failure was more prevalent in patients with single chamber compared to dual chamber pacemakers, (DDD(R) 18% vs 35% VVI(R), p<0.008), and those with chronic atrial fibrillation (AF) compared to those with sinus rhythm (42% vs 21%, p=0.003). Decreasing 6-minute walk distance, history of ischaemic heart disease and years of pacing were independently associated with the presence of heart failure (combined R=0.572, p<0.001). Conclusions Heart failure due to left ventricular systolic dysfunction is common in the paced population. Only a minority of these had a pre-existing diagnosis and a smaller proportion were on ‘optimal’ therapy. Echocardiographic screening of this high-risk population is justified to improve rates of diagnosis and treatment of heart failure.
Bibliography:local:0.3001994.1143
Correspondence to: S D. R. Thackray, MRCP, Castle Hill Hospital, University of Hull, X-ray 3, Entrance 3, Cottingham, Hull HU16 5JQ, UK. Tel: +44-1482-624073; fax: +44-1482624071
 E-mail address: simonthackray@hotmail.com
ark:/67375/HXZ-FWFQ7DJC-Z
istex:433F3D2D118AD6DE7CD0A814DC26DE73BE947CD1
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-News-3
content type line 23
ISSN:0195-668X
1522-9645
DOI:10.1016/S0195-668X(03)00199-4